Data compiled by Redley Lamar · ChainSifter Intelligence
3Suppliers
10Customers
3Debt Items
16Related Chains
Source-Backed Evidence Depth
GeneDx Holdings Corp. (WGS) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
17Total relationships
2Distinct source URLs
10High confidence
0.791Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
GeneDx Holdings Corp. Suppliers
Ticker
Name
Confidence
Evidence
ONE-SUPPLIER
ONE-SUPPLIER
85%
One supplier accounted for approximately 31 % and 25 % for the three months ended March 31, 2026 and 2025, respectively.
Reciprocal relationship from FLGT graph: supplier of the next generation sequencers and associated reagents we use to perform our genetic tests and as the sole provider of maintenance and repair serv…
Reciprocal relationship from OPK graph: t, and lower costs related to Somatrogon (hGH-CTP) following the closure of open-label extension studies in countries where it has received marketing authoriza…
GeneDx Holdings Corp. Customers
Ticker
Name
Confidence
Evidence
GENETICISTS
GENETICISTS
90%
Leading position: 80% market share driven by superior accuracy, broad access, and cutting-edge discovery Continued growth: Largest contributor to revenue today with room to grow via ongoing panel con…
PAYOR-GROUP-A
PAYOR-GROUP-A
90%
Payor group A (1) 26 % 24 % 21 % 18 %
PAYOR-GROUP-B
PAYOR-GROUP-B
90%
Payor group B (1) 31 % 32 % 26 % 27 %
PEDIATRIC-SPECIALISTS
PEDIATRIC-SPECIALISTS
85%
Pediatric specialists continue drive high growth Significant share: Over 30% of pediatric neurologists now order from us with continued growth ahead
PEDIATRICIANS
PEDIATRICIANS
80%
Massive market: 600K patients diagnosed with DD/ID by 25K pediatricians annually First mover to an untapped market with the #1 genetic test in hand
Reciprocal relationship from FLGT graph: Reciprocal relationship from WGS graph: Reciprocal relationship from FLGT graph: Reciprocal relationship from WGS graph: Reciprocal relationship from FLGT gra…
CMLS-HOLDINGS-LLC
CMLS-HOLDINGS-LLC
62%
mpact of ASU 2025-12 on its consolidated financial statements and related disclosures. Recently Adopted Accounting Pronouncements In September 2025, the FASB issued ASU 2025-06, Intangibles – Goodwil…
PERCEPTIVE-CREDIT-HOLDINGS
PERCEPTIVE-CREDIT-HOLDINGS
62%
ggering event described above, the Company evaluated the recoverability of the long-lived assets associated with the Fabric Genomics reporting unit. The Company compared the carrying value of the ass…
SEMA4-HOLDINGS-CORP
SEMA4-HOLDINGS-CORP
62%
. Upon the receipt of the payoff amount, the Credit Agreement was terminated, and all security interests and liens on the Company’s assets were released. For the three months ended March 31, 2026, t …
USA-LLC
USA-LLC
62%
General and Administrative Selling, general and administrative expense increased by $24.1 million, or 48%, to $74.6 million for the three months ended March 31, 2026, from $50.5 million for the three…
GeneDx Holdings Corp. Debt Obligations
Instrument
Description
Confidence
Evidence
WGS-DEBT-13550
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2021-12-31.
WGS-DEBT-13549
Warrants outstanding: 1204000
90%
xbrl warrant detail from xbrl 2025-12-31.
WGS-DEBT
Debt stack $168.2M
90%
Market cache reports total debt of $168.2M.
GeneDx Holdings Corp. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for GeneDx Holdings Corp..
GeneDx Holdings Corp. Ownership
Holder
Name
Confidence
Evidence
WGS-OWNER-CORVEX-MANAGEMENT-LP
Corvex Management LP
90%
13F overlay lists Corvex Management LP as top holder; 250 tracked holders.
